Company Filing History:
Years Active: 2023
Title: Mark C Smales: Innovator in Mammalian Expression Systems
Introduction
Mark C Smales is a notable inventor based in Canterbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of expression systems for mammalian cells. His work has implications for various applications in genetic engineering and therapeutic development.
Latest Patents
Mark C Smales holds a patent for a mammalian expression system. This innovative system facilitates the heterologous expression of a nucleic acid sequence of interest in mammalian cells. The patent includes several genetic entities, such as a nucleic acid sequence encoding a functional Epstein Barr virus nuclear antigen 1 (EBNA-1) and a nucleoside diphosphate kinase A (NDPK-A). The system is designed to enhance the expression of nucleic acid sequences, which can be crucial for various biotechnological applications.
Career Highlights
Mark C Smales is associated with Lonza Biologics Plc, a leading company in the life sciences sector. His work at Lonza has allowed him to focus on advancing biopharmaceutical manufacturing processes. His expertise in mammalian cell systems has positioned him as a key figure in the field.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Robert Young and James D Budge. These collaborations have contributed to the advancement of research and development in biotechnology.
Conclusion
Mark C Smales is a distinguished inventor whose work in mammalian expression systems has the potential to impact the biotechnology industry significantly. His contributions continue to pave the way for advancements in genetic engineering and therapeutic applications.